PLUS THERAPEUTICS, Inc. Common Stock PSTV
$5.01
-7.56%
at last close
Market Cap$34.49 million
P/E Ratio—
Div Yield—
Volume98.6K
52-Week Range
$2.90$23.43
Key Stats
- Today's Range
- $5.00 – $5.46
- 50-Day Range
- $2.90 – $8.00
- 52-Week Range
- $2.90 – $23.43
- Volume
- 99K shs
- Average Volume
- 138K shs
- Market Cap
- $34.49 million
- P/E Ratio
- —
- Dividend Yield
- —
Valuation
- P/E Ratio
- —
- Price / Book
- 2.88
- Price / Sales
- 6.66
Short Interest
- Short Interest
- 3.73%
- Days to Cover
- 1.00
Financials (TTM)
- Revenue
- $5.18 million
- Net Income
- $-11,931,000
- Net Margin
- -230.24%
- Return on Equity
- -99.75%
- Debt-to-Equity
- —
About PLUS THERAPEUTICS, Inc. Common Stock
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, commercializing and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).
Related Stocks
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.